Applications Publishes 18 April 2001
Published: 19-Jan-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).
Container with cryopreserved biological material and method for thawing this material
Universitaetsklinikum Freiburg 1092646*Lockable pill containers
Apothecary Products 1092725*Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis
EntreMed 1091726* Microparticle formulation for inhalation
Quadrant Healthcare 1091729*Utilisation of growth factors for the production of medicaments
White Spot 1092730*Anti-inflammatory pharmaceutical formulations
Norton Healthcare 1092731*Effervescent drug delivery for oral administration
Cima Labs 1091732*(-)-psudoephidrine as a sympathomimetic drug
Warner-Lambert 1091733*Method for reducing the effects of radiation therapy on animal skin and mucosa
Colgate-Palmolive 1092734*Application for utility patent for improved enriched platelet wound healant
Analoguous Wound Therapy 1092735*Inhibitors of prenyl-protein transferase
Merck 1091736* Calcium channel blockers
Neuromed Technologies 1091737*Bicyclic SPLA 2 inhibitors
Eli Lilly 1091738*Method for inhibiting C-JUN expression using JAK-3 inhibitors
Parker Hughes Institute 1091739*Semi-solid aqueous preparations for oral applications of totrazuril sulphone
Bayer 1091740*Azepine derivatives having effects on serotonin-related systems
Eli Lilly 1091741*Indium photosensitisers for PDT
Miravant Pharmaceuticals 1091742*Inositolphosphoglycan and ribose for treatment of ischaemia-reperfusion injury
University College London 1091743*1-octadecyl-2-methyl-SN-glycero-3-phosphocholine (ET18OCH3) for the treatment of human carcinoma of the breast
Medmark Pharma 1091744*Treatment of hyperproliferative disorder
Children's Hospital of Los Angeles 1091745* Use of iso-osmotic saline solutions, method for preparing same and cerumenolytic medicines based on said solutions
Laboratoires Goemar 1091746*Use of iso-osmotic saline solutions, method for preparing same and medicine based on said solutions
Laboratoires Goemar 1091747*A pharmaceutical formulation useful for the treatment of hepatitis B, hepatitis C and other viral infections of the liver and a process for its preparation
University of Madras 1091748*Compounds and methods for diagnosis of tuberculosis
Corixa Corporation 1091749*Cerebrospinal and vascular pharmaceutical compsn and process for preparing the same
Keep, Marcus 1091750*Trimeric antigenic O-linked glycopeptide conjugates, methods of preparation and uses thereof
Sloan-Kettering Institute for Cancer Research 1091751*Compsns comprising endotoxin neutralising protein and derivatives and uses thereof
Associates of Cape Cod 1091752*Antiproliferative and antiviral proteins and peptides
Envision Biomedical Consulting 1091753* Crosslink-stabilised indolicidin analogues
The Regents of the University of California 1091754*Particulate delivery stystems and methods of use
Alliance Pharmaceuticals 1091755*Haemophilus parasius vaccine and diagnostic
Akzo Nobel 1091756*Alpha-emitting constructs and uses thereof
Sloan-Kettering Institute for Cancer Research 1091757*Method of activating an inactive solution
Digibio 1091758*Compsn for the induction of apoptosis in target cells
University of Dundee 1091759*Transgene expression in polarised cells
Genzyme 1091762*Antiviral and retroviral radioimmunomedicaments based on alpha-emitters and beta-emitters
Bergter, Wolfgang 1091763*Methods for reducing adentitious agents and toxins and cell culture reagents produced thereby
Introvirogen Corp 1091765*Malodour counteracting treatment
University of Southampton; Reckitt & Colman 1091766*Treatment of airborne allergens
University of Southampton; Reckitt & Colman 1091767*Treatment of airborne microorganisms
University of Southampton; Reckitt & Colman 1091768*Novel retinoids and uses thereof
The UAB Research Foundation 1091924*Process for the preparation of substituted propenoic acid esters
Vyas, Sharad Kumar 1091927*Novel acyl pseudodipeptides, preparation method and pharmaceutical compsns containing same
OM Pharma 1091928*Secondary aspartic acid amide esters
Minnesota Mining and Manufacturing 1091929*C-terminal modified oxamyl dipeptides as inhibitos of the ICE/CED-3 family of cysteine proteases
Idun Pharmaceuticals 1091930*Preparation of quinonediamines from phenylenediamines using oxygen and a metal or metal salt catalyst
Flexsys America 1091931*Chiral stationary phases for enantiomers separation and their preparation
Societa' Cooperativa Centro Richerche Poly-Tech a Responsibilita' Limitata 1091932*Substituted B-diketones and their use
Orion Corp 1091933*Alkyl ketones as potent anti-cancer agents
Parker Hughes Institute 1091934*Method for preparing 2-nitr0-5-(phenylthio)-anilines
Bayer 1091935*Method for making hydroxy-25-ene-vitamin D complexes
Bone Care International. 1091936*Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compsns containing them
Adir et Compagnie 1091937*Antihistaminic piperidine derivatives and intermediates for the preparation thereof
Aventis Pharmaceutical 1091938*ubstituted quinolin-2(1H)-ones useful as HIV reverse transcriptase inhibitors
Du Pont Pharmaceuticals 1091939*Method for preparing 1-alkyl-pyrazol-5-carboxylic acid esters
Bayer 1091940*Novel benzimidazoles as corticotropin release factor antagonists
Du Pont Pharmaceuticals 1091941*Potassium channel blocking agents
Neurosearch 1091942*Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune and respiratory diseases
Pfizer 1091943*1,3-benzodiazepin-2-ones and 1,3-benzooxazepin-2-ones useful as HIV reverse trasnciptase inhibitors
Du Pont Pharmaceuticals 1091944*Cyclic carbamates and isoxazolidines as IIB/IIIA antagonists
Du Pont Pharmaceuticals 1091945*New 2-aminothiazol-fused-2-aminoindans and 2-aminotetralins and their use
Wikstroem, Hakan Vilhelm 1091946*Alpha-(1-piperazinyl)acetamido arenecarboxylic acid derivatives as antidiabetic agents
Merck Patent 1091947*Tubulin-binding compounds (COBRA)
Parker Hughes Institute 1091948*6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperzin-1-yl)chromane derivatives; dopamine receptor subtype specific ligands
Neurogen 1091949*Substituted benzopyran derivatives as their use as anticonvulsants
SmithKline Beecham 1091950*Novel polyoxypropylenepolyoxyethylene vitamin E and preparation thereof
Kim, Young-Dae; Park, Keun Ja; Kim, Jung Soo; Kim, Ji Soo 1091951*Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer
Biochem Pharma 1091952*Novel benzothiephines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
GD Searle 1091953*Process for producing (8-chloro-3,10-dibromo-6,11-dihydro-5H-benzo-5,6)cyclohepta-1,2-B]pyridin-11-yl)-1-piperidine
Schering 1091954*Quinolines as serine protease inhibitors
Warner-Lambert 1091955*Muscarinic antagonists
Schering 1091956*Pyridin-aminomethyl-pyridine derivatives, their preparation and their use in the control of helicobacter pylori
Byk Gulden Lomberg Chemische Fabrik 1091957*Salts of paroxetine
SmithKline Beecham 1091958*Novel pyrrolo-(3,4-B)quinoline derivatives, method for the production and use thereof as a medicament
Macef 1091959*Bifunctional antagonists of cytokine-sensitive protein kinase activation cascades and methods for use as anti-inflammatory agents
Regents of the University of California 1091960*Imidazo-pyridines, -pyridazines, and triazines as corticotropin releasing factor antagonists
Du Pont Pharmaceuticals 1091961*Indolocarbazole derivatives useful in the treatment of neurodegenerative diseases and cancer
Bayer 1091962*Lithium bisoxalatoborate, the production thereof and its use as a conducting salt
Chemetall 1091963*Cavity-induced allosteric modication of intermolecular interactions and methods of identifying compounds that effect the same
The Trustees of the University of Pennsylvania 1091974*Novel cyclosporin with improved activity profile
Debio-Pharm 1091975*Peptides from Varicella-zoster and other viruses for HIV-2 diagnosis and therapy
Peptide Solutions 1091976*A method of identifying hormone receptor ligands
Allergan Sales 1091977*Synthetic spiroketal pyranes as potent anticancer agents
Parker Hughes Institute 1091978*Seeding crystals for the preparation of peptides or proteins
Novo Nordisk 1091979*Compsns and methods for identifying apoptosis signalling pathway inhibitors and activators
The Regents of the University of Michigan 1091980*Novel ion exchange porous resins for solid phase extraction and chromatography
Waters Investments 1091981*Water-absorbing polymers with supramolecular hollow molecules, method for producing the same and use of the same
Stockhausen 1091983*Popylene olefin copolymers
Exxon Chemical Patents 1091984*
